Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudhakar M Pai

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology in Drug Development|March 31, 2021
Hemodialysis Clearance of Enarodustat (JTZ-951), an Oral Erythropoiesis Stimulating Agent, in Patients with End-Stage Renal DiseaseSudhakar M Pai, Hiroyuki Yamada
Journal of Clinical Pharmacology|February 9, 2022
Will the Pharmacologically Meaningful Half-Life Please Stand Up?Philip Chaikin, Sudhakar M Pai
Clinical Pharmacology in Drug Development|November 17, 2023
Effect of the Phosphate Binder Sevelamer Carbonate on the Bioavailability of Enarodustat, an Oral Erythropoiesis Stimulating AgentSudhakar M Pai, Hiroyuki Yamada
Journal of Clinical Pharmacology|October 15, 2021
Off-Label Use of Ketamine: A Challenging Drug Treatment Delivery Model With an Inherently Unfavorable Risk-Benefit ProfileSudhakar M Pai, Jean-Michel Gries,
Clinical Pharmacology in Drug Development|June 3, 2023
Evaluation of Drug-Drug Interaction Potential of Enarodustat (JTZ-951) Using a Cytochrome P450 Probe CocktailSudhakar M Pai, Hiroyuki Yamada, Hiroyuki Murata
Journal of Clinical Pharmacology|May 11, 2019
Pharmacokinetics of Lapatinib, a Nonrenally Cleared Drug, in Patients With End-Stage Renal Disease on Maintenance HemodialysisSudhakar M Pai, Philip Chaikin, Jolene Kay Berg
Journal of Clinical Pharmacology|August 22, 2022
Drug Lawsuit Advertisements and the Importance of Physician Consultation Prior to Voluntary Medication Withdrawal or TransitionKenneth T Moore, Sudhakar M Pai, Mark Rogge, et al.
Journal of Clinical Pharmacology|September 4, 2022
Evaluation of Hemoglobin Response to Treatment With Enarodustat Using Pharmacometric Approach in Japanese Anemic Patients With Chronic Kidney DiseaseShinya Naruhashi, Takashi Fujii, Hiroyuki Yamada, et al.
The AAPS Journal|July 25, 2009
Population pharmacodynamic parameter estimation from sparse sampling: effect of sigmoidicity on parameter estimatesSudhakar M Pai, Suzette Girgis, Vijay K Batra, et al.
Clinical Pharmacology in Drug Development|May 19, 2023
Pharmacokinetics of Enarodustat in Non-Japanese and Japanese Healthy Subjects and in Patients With End-Stage Renal Disease on HemodialysisSudhakar M Pai, Siva Rama Prasad Kambhampati, Shinya Naruhashi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology in Drug Development|March 31, 2021
Hemodialysis Clearance of Enarodustat (JTZ-951), an Oral Erythropoiesis Stimulating Agent, in Patients with End-Stage Renal DiseaseSudhakar M Pai, Hiroyuki Yamada
Journal of Clinical Pharmacology|February 9, 2022
Will the Pharmacologically Meaningful Half-Life Please Stand Up?Philip Chaikin, Sudhakar M Pai
Clinical Pharmacology in Drug Development|November 17, 2023
Effect of the Phosphate Binder Sevelamer Carbonate on the Bioavailability of Enarodustat, an Oral Erythropoiesis Stimulating AgentSudhakar M Pai, Hiroyuki Yamada
Journal of Clinical Pharmacology|October 15, 2021
Off-Label Use of Ketamine: A Challenging Drug Treatment Delivery Model With an Inherently Unfavorable Risk-Benefit ProfileSudhakar M Pai, Jean-Michel Gries,
Clinical Pharmacology in Drug Development|June 3, 2023
Evaluation of Drug-Drug Interaction Potential of Enarodustat (JTZ-951) Using a Cytochrome P450 Probe CocktailSudhakar M Pai, Hiroyuki Yamada, Hiroyuki Murata
Journal of Clinical Pharmacology|May 11, 2019
Pharmacokinetics of Lapatinib, a Nonrenally Cleared Drug, in Patients With End-Stage Renal Disease on Maintenance HemodialysisSudhakar M Pai, Philip Chaikin, Jolene Kay Berg
Journal of Clinical Pharmacology|August 22, 2022
Drug Lawsuit Advertisements and the Importance of Physician Consultation Prior to Voluntary Medication Withdrawal or TransitionKenneth T Moore, Sudhakar M Pai, Mark Rogge, et al.
Journal of Clinical Pharmacology|September 4, 2022
Evaluation of Hemoglobin Response to Treatment With Enarodustat Using Pharmacometric Approach in Japanese Anemic Patients With Chronic Kidney DiseaseShinya Naruhashi, Takashi Fujii, Hiroyuki Yamada, et al.
The AAPS Journal|July 25, 2009
Population pharmacodynamic parameter estimation from sparse sampling: effect of sigmoidicity on parameter estimatesSudhakar M Pai, Suzette Girgis, Vijay K Batra, et al.
Clinical Pharmacology in Drug Development|May 19, 2023
Pharmacokinetics of Enarodustat in Non-Japanese and Japanese Healthy Subjects and in Patients With End-Stage Renal Disease on HemodialysisSudhakar M Pai, Siva Rama Prasad Kambhampati, Shinya Naruhashi, et al.
Pageof 2